Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hepatitis C Screening in Intravenous Drug Users Under Treatment With Methadone: An Action Reserch Study



Zadeh SM1 ; Kassaian N2 ; Ataei B3 ; Nokhodian Z4 ; Adibi P4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Governance of Laboratories, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Infectious and Tropical Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Infectious Diseases, School of Medicine and Infectious and Tropical Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Gastroenterology, School of Medicine and Infectious and Tropical Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2011

Abstract

Background: Intravenous drug users (IVDUs) are the most at risk group for viral hepatitis C and injection drug is responsible to more than 60% of HCV infected new cases worldwide. Hepatitis C screening in centers for methadone maintenance treatment (MMT) has several benefits in harm reduction stategies. Methods: In an action research study, after coordinating centers for methadone maintenance treatment, questiononaires including demographic and risk factors of HCV were sent to 80 active centes in Isfahan province to complete and add their result for HCV-Ab test. Finding: Only seven centers with 1055 members, sent their completed questionaires to administrators, but most of documents were without any HCV-Ab test results. Overall, 74 (7.0%) participants were positive for hepatitis C. Conclusion: The results of this study indicated serious problem in execution which was due to lack of cooperration of the centers' mannagers, stuffs, and members. Hence, it is recommended to do active intervention and consider a reward for future investigators.
Related Docs
View other Related Docs
1. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
2. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
3. Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description, Journal of Isfahan Medical School (2011)
4. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
5. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)
6. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
7. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
8. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (26)
Nazila Kassaian (21)
Other Related Docs
9. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)
10. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)
11. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
12. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
13. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
14. Relative Frequency of Early Virologic Response to Treatment With a Combination of Conventional Interferon and Ribavirin in Patients With Chronic Hepatitis C, Journal of Isfahan Medical School (2012)
15. Systematic Review and Meta-Analysis on the Age-Specific Seroprevalence of Hepatitis a in Iran, Journal of Research in Medical Sciences (2014)
16. Isolation of Hepatitis C Virus in Norjizac Vials, Hepatitis Monthly (2010)
17. Sd1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-Cost, Fixed-Dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase Iii Clinical Trial, Clinical Infectious Diseases (2020)
18. Seroprevalence of and Risk Factors Associated With Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Among Prisoners in Iran, Infectious Diseases in Clinical Practice (2007)
19. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)
20. Seroprevalence of Hepatitis C Infection Among Laboratory Health Care Workers in Isfahan, Iran, International Journal of Preventive Medicine (2012)
21. Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection, Archives of Iranian Medicine (2005)
22. Correlation Between Il-28 Polymorphism and Spontaneous Clearance in Hcv Patients: Systematic Review and Meta-Analysis, Archives of Virology (2021)
23. Comparing the Effectiveness of a Short-Term Double-Dose Hepatitis B Vaccination Schedule With the Standard 3-Dose Schedule: A Randomized Clinical Trial, Tehran University Medical Journal (2011)
24. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline, Hepatitis Monthly (2016)
25. Seroprevalence of Hbv, Hcv and Hiv Infection Among Intravenous Drug Users in Shahr-E-Kord, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2008)
26. Comparing Opium Tincture and Methadone for Medication-Assisted Treatment of Patients With Opioid Use Disorder: Protocol for a Multicenter Parallel Group Noninferiority Double-Blind Randomized Controlled Trial, International Journal of Methods in Psychiatric Research (2019)
27. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
28. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
29. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
30. High Risky Behaviors Among Intravenous Drug Users in Isfahan, Iran: A Study for Hepatitis C Harm Reduction Programs, International Journal of Preventive Medicine (2012)
31. Perceived Barriers to Methadone Maintenance Treatment Among Iranian Opioid Users, International Journal for Equity in Health (2018)
32. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002), Hepatitis Monthly (2008)
33. Effectiveness of Relapse Prevention Cognitive- Behavioral Model in Opioid -Dependent Patients Participating in the Methadone Maintenance Treatment in Iran, Iranian Journal of Public Health (2013)
34. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
35. Risk Prison and Hepatitis B Virus Infection Among Inmates With History of Drug Injection in Isfahan, Iran, The Scientific World Journal (2013)
36. Prevalence of Hiv/Hcv/Hbv Infections and Drug-Related Risk Behaviours Amongst Idus Recruited Through Peer-Driven Sampling in Iran, International Journal of Drug Policy (2010)
37. Prevalence and Risk Factors of Hiv, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran, Hepatitis Monthly (2012)
38. Retention Rate in Methadone Maintenance Treatment and Factors Associated Among Referred Patients From the Compulsory Residential Centers Compared to Voluntary Patients, Frontiers in Psychiatry (2023)
39. Effects of Roy's Adaptation Model on Quality of Life in People With Opioid Abuse Under Methadone Maintenance Treatment: A Randomized Trial, Ethiopian journal of health sciences (2023)
40. Hepatitis C Virus Genotype Frequency in Isfahan Province of Iran: A Descriptive Cross-Sectional Study, Virology Journal (2010)
41. The Estimation of Direct Medical Costs of Treating Patients With Chronic Hepatitis B and C in Iran, International Journal of Preventive Medicine (2012)
42. Co-Infection of Human Immunodeficiency Virus, Hepatitis C and Hepatitis B Virus Among Injection Drug Users in Drop in Centers, Journal of Research in Medical Sciences (2014)
43. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
44. The Assessment of Hepatitis B Seroprevalence in Persons With Intravenous Drug Use History in the Isfahan Province: Community-Based Study, Journal of Research in Medical Sciences (2014)
45. Hepatitis B and C Among Women With Illegal Social Behavior in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2011)
46. Seroprevalence and Risk Factors of Hepatitis C Virus Among Juveniles in Correctional Center in Isfahan, Iran, International Journal of Preventive Medicine (2012)
47. A Multicenter Study to Evaluate the Safety and Efficacy of Heberon (Interferon Alfa-2B) in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Iran, Medical Journal of the Islamic Republic of Iran (2005)
48. Effects of a Comprehensive Educational Program on Health Behaviors and Awareness of Hiv, Hepatitis B, and Hepatitis C in Men With Substance Use Disorders, Middle East Current Psychiatry (2024)
49. Seroprevalence of Hepatitis B Infection and Associated Risk Factors Among Drug Users in Drop-In Centers of Isfahan, Iran, International Journal of Preventive Medicine (2018)
50. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)